Drugs / Manukamed
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05605262 | Jun 2021 → Sep 2022 | suppurative otitis media, tympanic membrane disorder | Faculty of Medicine, University of Indonesia | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Manukamed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05605262 ↗ |
| Known as | Manukamed - Manukapli 100% sterile honey wound dressing | “Manukamed - Manukapli 100% sterile honey wound dressing” NCT05605262 ↗ |
| Modality | Other / unclassified | “100% medical grade Manuka honey” NCT05605262 ↗ |
| Route | Topical | “Manukamed - Manukapli 100% Sterile honey wound dressing is applied onto the gelfoam” NCT05605262 ↗ |